News for Agent

Daily business news: funding, M&A, launches

Leadership

Ramsay Santé Proposes Frédéric Collet as Independent Chairman Ahead of 52.79% Stake Distribution

By ·

Key takeaways

  • Ramsay Santé proposed Frédéric Collet as independent Chairman, subject to his appointment as a Director at the General Meeting on December 4, 2026.
  • Pascal Roché, Alexandra Boleslawski, Virginie Banet, Alexandre de Palmas and Fredrik Reinfeldt were proposed as Directors, effective on completion of the distribution.
  • The planned in-specie distribution of Ramsay Health Care's 52.79% stake is expected on December 9, 2026, subject to RHC shareholder approval on November 24, 2026.

Ramsay Santé proposed Frédéric Collet as independent Chairman of its Board of Directors on November 16, 2026, alongside five director appointments, as the French hospital group prepares for Ramsay Health Care's planned distribution of its 52.79% shareholding. The proposal was announced by GlobeNewswire.

Collet's Path From Novartis France to the Chair

Frédéric Collet is proposed as an independent director and Chair, subject to his appointment as a Director by the General Meeting on December 4, 2026 and completion of the planned distribution. Collet was President of Novartis France from 2017 to 2022 and chaired LEEM, the French pharmaceutical industry association, from 2019 to 2022. Since 2023 he has been Founder and President of Bionnassay-Consult, Senior Advisor at Eurazeo and President of the Filière Intelligence Artificielle & Cancers. He sits on Ramsay Santé's Mission Committee and will resign from it following the distribution.

Shareholders will also be asked to approve Pascal Roché, the group's Chief Executive Officer, along with Alexandra Boleslawski, Virginie Banet, Alexandre de Palmas and Fredrik Reinfeldt as Directors. The appointments would take effect upon, and subject to, completion of the distribution. The five Directors appointed on Ramsay Health Care's proposal will resign upon the same condition. Following the distribution, the Board would have eleven directors, comprising four women (44.4%) and five men (55.6%), with 55.6% of members independent (five out of nine) excluding employee representatives. The Board would then implement the Connecting Care 2030 strategic plan, presented at a Capital Markets Day in September 2026.

Ramsay Santé's Refinancing and Shareholder Base

According to akta.pro company records, Ramsay Santé launched a €1.75 billion senior debt refinancing in June 2026, comprising a €200 million revolving credit facility and a €1.55 billion Term Loan B, extending senior debt maturities from 2031 to 2033. The same records show Ramsay Health Care owns a 52.79% stake and plans to distribute it to its own shareholders by year-end 2026, while Crédit Agricole Assurances holds 39.82%.

Listing Approval and Interim Results Before the Vote

Ramsay Santé received approval from the Australian Securities Exchange for a foreign exempt listing, enabling eligible Ramsay Health Care shareholders to trade interests via CHESS Depositary Interests, TradingView reported on November 12, 2026. On November 5, 2026, GlobeNewswire reported that Ramsay Santé posted first-quarter 2026 revenue of €1.233 billion, up 2.9%, and EBITDA of €120.7m, up 7.5%, with net leverage at 5.1x. On October 19, 2026, GlobeNewswire reported that Ramsay Générale de Santé filed its 2026 Universal Registration Document with the AMF.

December Votes and Distribution Date

The transaction remains subject to Ramsay Health Care shareholder approval at a General Meeting scheduled for November 24, 2026, and to receipt of required authorisations. Ramsay Santé shareholders will vote on the appointments on December 4, 2026, and the distribution is currently expected on December 9, 2026.

Companies in this story

Sources

Machine-readable: Markdown · JSON